Warberg Asset Management’s Zura Bio ZURA Stock Holding History

Warberg Asset Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$102K	–	291
2022 Q4	$102K	Hold	10,000	–	–	0.02%	139
2022 Q3	$101K	Hold	10,000	–	–	0.02%	152
2022 Q2	$100K	Hold	10,000	–	–	0.02%	129
2022 Q1	$99K	Hold	10,000	–	–	0.02%	134
2021 Q4	$99K	Hold	10,000	–	–	0.02%	131
2021 Q3	$99K	Buy	+10,000	New	+$98.1K	0.02%	138

Other funds holding ZURA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SAMU

SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Warberg Asset Management's ZURA Position: Q1 2023 in Review

Warberg Asset Management sold out of Zura Bio (ZURA) in Q1 2023, closing a stake of 10,000 shares — an estimated $102K sold.

Warberg Asset Management first reported a position in ZURA in Q3 2021 and held it in 6 quarters. The position peaked at $102K in Q4 2022. 3 funds tracked by Wall St. Rank hold ZURA as of Q1 2023.

Warberg Asset Management reported no remaining Zura Bio position as of Q1 2023 after selling out during the quarter.
Warberg Asset Management sold 10,000 Zura Bio shares in Q1 2023, an estimated $102K.
Warberg Asset Management first reported a position in Zura Bio in Q3 2021 and held it in 6 quarters.
Warberg Asset Management's Zura Bio position peaked at $102K in Q4 2022.
3 funds tracked by Wall St. Rank held Zura Bio as of Q1 2023.

Based on Warberg Asset Management's 13F filing for Q1 2023, filed 15 May 2023.